Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by Minty_33on Feb 05, 2020 6:27pm
86 Views
Post# 30648510

RE:RE:RE:RE:RE:RE:RE:Maybe They Know something

RE:RE:RE:RE:RE:RE:RE:Maybe They Know something
Wonder if finally we'll get some pre-clinical data at Noblecon and if lucky, an indication of why they have chosen to do a beta glucan stand alone study. After approximately 7 months of doing research, somebody knows something and I'm going to guess that BG works with statins and maybe even better than anticipated hence the stand alone study. Imagine if it works without statins....the competition would be blown away because of the natural composition and no side effects. Look below

Pfizer's Lipitor revenue worldwide 2003-2018
During 2018, Pfizer's Lipitor generated nearly 2.1 billion U.S. dollars of revenue. This was the second year in a row with a reported increase after the record-low in 2016, with revenues of 1.76 billion dollars.
Bullboard Posts